Kobayashi Pharmaceutical Co., Ltd.

Kobayashi Pharmaceutical Co., Ltd.

39.80
EUR
-0.20
(-0.50%)
Nov 10Next Earn

Important Dates

Kobayashi Pharmaceutical Co., Ltd.'s next confirmed earnings release is scheduled for November 10, 2026.

Earnings Date11/10/2026

Share Statistics

As of June 30, 2026, Kobayashi Pharmaceutical Co., Ltd. has 74.34M shares outstanding.

Shares Outstanding74.34M

Financial Position

As of June 30, 2026, Kobayashi Pharmaceutical Co., Ltd. maintains a current ratio of 3.28, meaning it holds 3.3x the short-term assets needed to cover near-term liabilities.

Current Ratio3.28
Quick Ratio1.51
Debt / Equity0.34

Financial Efficiency

These figures cover the twelve months ended June 30, 2026.

Employee Count3,702.00

Balance Sheet

EUR

As of June 30, 2026, Kobayashi Pharmaceutical Co., Ltd. holds 308.67M in cash and equivalents against 3.89M in total debt, resulting in a net debt position of -253.22M. Total book value stands at 1.13B, with working capital of 467.12M providing operational flexibility.

Cash & Cash Equivalents308.67M
Total Debt3.89M
Net Debt-253.22M
Equity (Book Value)1.13B
Book Value Per Share15.19
Working Capital467.12M

Stock Splits

Kobayashi Pharmaceutical Co., Ltd.'s most recent stock split took place on June 28, 2016 with a 1:2 split ratio.

Last Split Date6/28/2016
Split Ratio1:2